Whole-body electromyostimulation
Whole-body electromyostimulation has been studied in 7 papers since 2022: 4 trials in people, 2 reviews; 2 in the past year. The newest paper, Mar 16, 2026: “Effects of Whole-Body Electromyostimulation on the Thickness of Appendicular and Respiratory Muscles, Functionality, and Frailty in Patients From a Transitional Care Unit: A Randomized Clinical Trial Protocol”.
7 papers study it3 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Gannan Medical University and 1 more
- Human trial4
What did studies of Whole-body electromyostimulation find?
3Studies of Whole-body electromyostimulation measured 3 outcomes; the most studied are inflammation (1 study), skeletal muscle mass index (1) and sarcopenia Z-score (1).
Inflammation
no changein humans1
1 study
Inflammation
no changein humans1
Whole-body electromyostimulation has no effect on inflammation in humans.
“Both WB-EMS and protein supplementation intervention had no significant effects on metabolic and inflammatory biomarkers.”
Reviewsarcopenic obesity
Experimental gerontology
Skeletal muscle mass index
upin humans1
1 study
Skeletal muscle mass index
upin humans1
Whole-body electromyostimulation increases skeletal muscle mass index in humans (MD = 1.27, 95% CI: 0.66 to 1.88).
“increased skeletal muscle mass index (SMI) (MD = 1.27, 95 % CI: 0.66,1.88, P < 0.0001)”
Reviewsarcopenic obesity
Experimental gerontology
Sarcopenia Z-score
upin humans1
1 study
Sarcopenia Z-score
upin humans1
Whole-body electromyostimulation improves sarcopenia Z-score in humans (MD = -1.52, 95% CI: -2.27 to -0.77).
“WB-EMS training improved sarcopenia Z-score (MD = -1.52, 95 % CI: -2.27, -0.77, P < 0.0001)”
Reviewsarcopenic obesity
Experimental gerontology